Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

More On GRFS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials


Grifols, S.A. (GRFS)

-NasdaqGS
38.17 Down 0.05(0.13%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Grifols, S.A.
Avinguda de la Generalitat, 152-158
Parc de Negocis Can Sant Joan
Barcelona, 08174
Spain - Map
Phone: 34 935 71 22 00
Fax: 34 935 71 02 67
Website: http://www.grifols.com

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:12,615

Business Summary 

Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, Canada, and internationally. It specializes in providing infusion solutions, nutrition products, medical devices, and diagnostic instrumentation and reagents for use in hospitals and clinics. The company operates through four divisions: Bioscience, Diagnostic, Hospital, and Raw Materials and Others. The Bioscience division manufactures and sells plasma derivatives for therapeutic use, such as the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. This division offers plasma products, such as IVIG, Factor VIII, A1PI, and albumin; and intramuscular immunoglobulins, ATIII, Factor IX, and plasma thromboplastin components. The Diagnostic division focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products comprising analytical instruments and reagents for diagnostics, as well as blood bank products. This division primarily serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital division manufactures and installs products used by and in hospitals, including parenteral solutions, and enteral and parenteral nutritional fluids. The Raw Materials and Others division is involved in the sale of intermediate pastes and plasma products, as well as provision of engineering services to external companies. The company’s products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and a range of other medical conditions. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Grifols, S.A.

Key Executives 
 PayExercised
Mr. Victor Grifols Roura ,
Chairman, Chief Exec. Officer, Pres, Managing Director and Member of Appointments & Remuneration Committee
N/AN/A
Mr. Alfredo Arroyo Guerra ,
Chief Financial Officer and Corp. VP
N/AN/A
Mrs. Montserrat Lloveras Calvo ,
Chief Admin. Officer, Principal Accounting Officer and Controller
N/AN/A
Mr. Vicente Blanquer Torre ,
Chief Technology Officer
N/AN/A
Mrs. Eva Bastida Tubau ,
Chief Scientific Officer
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.